Not Signed In -
Bupropion |
Wellbutrin |
Clinical Trial: Maintaining Abstinence in Chronic Cigarette Smokers - 1
This study is currently recruiting patients.
Purpose
The purpose of this study is to evaluate the extended pharmacological and psychological treatment for chronic cigarette smokers.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Tobacco Use Disorder | Drug: Bupropion | Phase II |
MedlinePlus related topics: Smoking
Study Type: Interventional
Study Design: Treatment, Uncontrolled, Efficacy Study
Official Title: Maintaining Abstinence in Chronic Cigarette Smokers
Further Study Details:
Expected Total Enrollment: 400
Study start: December 2002
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
chronic cigarette smokers of at least 10 cigarettes per day
Inclusion Criteria:
multiple
Exclusion Criteria:
multiple
Location and Contact Information
Sharon M Hall, Ph.D. (415)476-7574 smh@itsa.ucsf.edu
California
San Francisco, San Francisco, California, United States; Recruiting
Gary Humfleet, Ph.D. 415-476-7674 hac@itsa.ucsf.edu
Study chairs or principal investigators
Sharon M Hall, Ph.D., Principal Investigator, University of California, San Francisco
More Information
http://www.ucsf.edu/nosmoke
Study ID Numbers: NIDA-15732-1; R01-15732-1
Record last reviewed: June 2004
Last Updated: November 18, 2004
Record first received: July 15, 2004
ClinicalTrials.gov Identifier: NCT00087880
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: June 2004
Last Updated: November 18, 2004
Record first received: July 15, 2004
ClinicalTrials.gov Identifier: NCT00087880
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
